Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 02, 2026
RTX Corporation (RTX): Can It Reach the $235 Analyst Target for a +27% Gain?

RTX Corporation (RTX): Can It Reach the $235 Analyst Target for a +27% Gain?

Key Takeaways

  • The central $235 price target is the arithmetic mean of more than 20 verified, current analyst price targets, which cluster around $234 and were rounded to a clean, reader-friendly level.
  • With RTX shares near $185.65, reaching $235 would require roughly a 27% advance—a substantial move.
  • Published analyst targets span a wide range of approximately $200 to $265, reflecting real disagreement about valuation and execution.
  • The strongest supports are a record $289 billion backlog, raised 2026 guidance, and robust defense and commercial aftermarket demand.
  • The biggest risks are a premium valuation, lingering engine-related supply-chain costs, and a recent pullback from the 52-week high.

Analyst Consensus and Price Targets

RTX Corporation is a diversified aerospace and defense company formed from the 2020 combination of Raytheon and United Technologies, operating through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. Across major aggregators, roughly two dozen analysts cover the stock, and the verified individual targets produce an arithmetic mean of about $234, which rounds to a $235 central target. That figure reflects the collective average, not any single firm's call. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry.

The low-to-high range is unusually wide—about $200 at the low end and $265 at the high end. Cautious voices cluster lower: UBS trimmed its target to $209 in late September 2026, while Bernstein lowered its target to $223 from $232. More constructive analysts sit higher, including Jefferies at $250, Susquehanna and Argus Research at $245, TD Cowen and Morgan Stanley at $240, and Deutsche Bank at $238. RBC Capital and Wells Fargo both carry $230 targets. The spread matters because it means the $235 level is achievable under the more bullish scenarios but sits well above the cautious view.

Current Market Position and Path to the Target

RTX shares closed around $185.65 at the end of September 2026, well below the 52-week high of $226.88 but comfortably above the 52-week low of $155.64. The stock trades at a price-to-earnings (P/E) ratio of roughly 32 on trailing earnings, with a dividend yield near 1.6% and a market capitalization around $250 billion. Reaching $235 would require about a 27% gain, a substantial move that would take the stock above its prior peak.

The path toward that level is grounded in fundamentals rather than sentiment. RTX raised its full-year 2026 outlook after second-quarter results: adjusted sales guidance moved to $95–$96 billion, adjusted EPS to $7.10–$7.25, and free cash flow to $8.50–$8.75 billion. Management cited 16% organic sales growth, double-digit defense and commercial aftermarket expansion, and margin gains across all three segments. A record $289 billion backlog—up 22% year over year—provides revenue visibility that many analysts cite in defending higher targets.

Factors That Could Support a Move Higher

  • Record backlog and demand: A $289 billion order book, including roughly $20 billion of Raytheon awards in the second quarter, supports multi-year revenue growth.
  • Raised guidance: The uplift to 8–9% organic growth and higher EPS and free-cash-flow ranges signals improving execution and pricing power.
  • Commercial aftermarket recovery: Strong Pratt & Whitney GTF aftermarket volumes and Collins Aerospace production ramps underpin margin expansion.
  • Defense tailwinds: Geopolitical demand for missiles, air-defense systems, and sensors continues to lift Raytheon bookings.
  • Analyst revision trend: Several firms raised targets through mid-2026 following the beat-and-raise quarter, a generally supportive signal.

Risks That Could Keep the Target Out of Reach

  • Valuation compression: A trailing P/E near 32 leaves little room for disappointment if growth or margins slow.
  • Engine and supply-chain costs: Ongoing powder-metal and GTF-related compensation, plus broader aerospace supply constraints, remain a drag on cash flow.
  • Cyclicality in commercial aerospace: Any cooling in airline aftermarket demand or aircraft production rates would pressure Collins and Pratt results.
  • Margin execution: Analysts note RTX's operational performance has historically lagged peers, and further proof of sustained improvement is still being sought.
  • Recent momentum: The stock's pullback from its 52-week high shows sentiment can shift quickly even when fundamentals hold up.

Technical Levels to Watch

The 52-week range of $155.64 to $226.88 frames the chart. The $226.88 prior high is the key resistance level to clear, and a $235 target sits just above it—meaning the stock would need to break decisively through its previous peak to reach the central target. On the downside, the $185 area around the current price is a notable zone to hold, with the psychological $180 and $170 levels below as potential support if selling resumes. The long-term trend remains constructive after a 140% five-year total return, but the recent decline underscores that prior highs act as meaningful resistance.

Time Horizon and Key Catalysts

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms vary and some update targets quarterly. The most important near-term catalyst is RTX's third-quarter earnings report, expected around late October 2026. Investors should watch for any revision to full-year guidance, Raytheon booking momentum and backlog trends, Pratt & Whitney GTF aftermarket volumes and powder-metal costs, free-cash-flow progress, and broader defense budget and interest-rate developments that influence valuation. Analyst target changes after earnings will signal whether the $235 level remains in view.

Using AI Tools to Monitor RTX

I often turn to Tickeron’s AI tools when evaluating stocks like this one to get a clearer picture of momentum and signals. The AI Daily Buy/Sell Signals platform stands out for its ability to scan market conditions in real time and flag potential shifts. It has become a regular part of my process for tracking names with wide analyst ranges, helping me stay on top of both technical and fundamental developments without constant manual reviews.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RTX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RTX's RSI Oscillator is staying in oversold zone for 18 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where RTX advanced for three days, in 231 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

RTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

RTX moved below its 50-day moving average on September 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RTX crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

The Aroon Indicator for RTX entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. RTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.811) is normal, around the industry mean (6.351). P/E Ratio (33.039) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (2.176) is also within normal values, averaging (2.564). Dividend Yield (0.015) settles around the average of (0.009) among similar stocks. P/S Ratio (2.868) is also within normal values, averaging (18.155).

The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 39.37B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -5%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -10%. DFSC experienced the highest price growth at 8%, while KITT experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -15%. For the same stocks of the Industry, the average monthly volume growth was 13% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 70
Price Growth Rating: 64
SMR Rating: 77
Profit Risk Rating: 75
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
RTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers

Industry AerospaceDefense

Industry
N/A
Address
1000 Wilson Boulevard
Phone
+1 781 522-3000
Employees
180000
Web
https://www.rtx.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.
RTX Corporation (RTX): Can It Reach the $235 Analyst Target for a +27% Gain?